share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Apr 22 08:07

Gainers

  • Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 34.2% to $2.59 during Monday's pre-market session. The company's market cap stands at $10.5 million.
  • NKGen Biotech (NASDAQ:NKGN) shares moved upwards by 32.0% to $1.46. The company's market cap stands at $33.2 million. The company's, Q4 earnings came out 4 days ago.
  • T2 Biosystems (NASDAQ:TTOO) shares moved upwards by 18.91% to $3.52. The company's market cap stands at $30.9 million.
  • CNS Pharma (NASDAQ:CNSP) shares increased by 18.26% to $0.24. The company's market cap stands at $2.5 million.
  • Altamira Therapeutics (NASDAQ:CYTO) stock moved upwards by 17.39% to $1.66. The market value of their outstanding shares is at $3.7 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock rose 11.18% to $0.36. The market value of their outstanding shares is at $2.3 million.

Losers

  • Vaxxinity (NASDAQ:VAXX) stock declined by 61.3% to $0.18 during Monday's pre-market session. The company's market cap stands at $23.3 million.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) stock declined by 37.82% to $1.25. The company's market cap stands at $6.8 million. The company's, Q4 earnings came out 4 days ago.
  • Adlai Nortye (NASDAQ:ANL) stock declined by 14.92% to $10.55. The company's market cap stands at $389.2 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock fell 13.89% to $1.52. The company's market cap stands at $1.5 million.
  • Revelation Biosciences (NASDAQ:REVB) shares declined by 13.12% to $1.95. The company's market cap stands at $3.1 million.
  • Qilian Intl Hldg Gr (NASDAQ:QLI) stock decreased by 10.63% to $0.7. The company's market cap stands at $24.9 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment